Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolfenamic Acid in Progressive Supranuclear Palsy
NCT04253132Phase 2Unknown
- Sponsor
- NeuroTau
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
A Phase 2 trial of tolfenamic acid in progressive supranuclear palsy (PSP), sponsored by NeuroTau. Status: unknown.
02
Drugs
tolfenamic acid
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT04253132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04253132.